Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's disease: Analysis of Baseline Factors

被引：0
|
作者：
Nicholas, A.
Singer, C.
Zhang, I.
Pappert, E.
Navia, B.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
426
引用
收藏
页码：S188 / S189
页数：2
相关论文
共 50 条
  • [1] APOMORPHINE SUBLINGUAL FILM FOR "OFF" EPISODES IN PARKINSON'S DISEASE: ANALYSIS OF BASELINE FACTORS
    Nicholas, A. P.
    Singer, C.
    Zhang, I.
    Navia, B.
    Pappert, E.
    [J]. PARKINSONISM & RELATED DISORDERS, 2023, 113 : 43 - 43
  • [2] IMPACT OF BASELINE FACTORS ON RESPONSE TO APOMORPHINE SUBLINGUAL FILM IN PATIENTS WITH PARKINSON'S DISEASE AND "OFF" EPISODES
    Nicholas, A.
    Singer, C.
    Robottom, B.
    Bhargava, P.
    Navia, B.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E85 - E85
  • [3] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's Disease: Impact on Dyskinesia
    Klos, K.
    Hui, J.
    Zhang, I.
    Pappert, E.
    Navia, B.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S180 - S180
  • [4] Dose optimization of apomorphine sublingual film for treating "OFF" episodes in Parkinson's disease*
    Olanow, C. Warren
    Stocchi, Fabrizio
    Peckham, Elizabeth L.
    De Pandis, Maria Francesca
    Sciarappa, Ken
    Navia, Bradford
    [J]. PARKINSONISM & RELATED DISORDERS, 2021, 93 : 27 - 30
  • [5] Efficacy of apomorphine sublingual film versus subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's Disease
    Stocchi, F.
    Rascol, O.
    Poewe, W.
    Chaudhuri, R.
    Kassubek, J.
    Manzanares, L. Lopez
    Leta, V.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S356 - S356
  • [6] Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Chaudhuri, R.
    Kassube, J.
    Manzanares, L. Lopez
    Leta, V.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S348 - S348
  • [7] Sublingual Apomorphine Manages Parkinson Disease Off Episodes
    Slomski, Anita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (08): : 701 - 701
  • [8] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's Disease: Impact on Impulse Control Disorders
    Espay, A.
    Markopoulou, K.
    Zhang, I.
    Pappert, E.
    Navia, B.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S170 - S171
  • [9] A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson's disease 'OFF' episodes
    Caughman, Christopher Y.
    Factor, Stewart
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (02) : 169 - 177
  • [10] Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson's Disease and "OFF" Episodes
    Hui, Jennifer
    Fox, Susan
    Neeson, William
    Bhargava, Parul
    Pappert, Eric
    Blum, David
    Navia, Bradford
    [J]. NEUROLOGY, 2020, 94 (15)
12345